The plant is reviewed for EU-GMP standards and anticipates to be completed and commissioned by the end of 2018, then it will go into operation in early 2019. The designed capacity is 250 million units a year. The total capital investment is 180 billion VND.
The factory was granted EU-GMP certification by the Portuguese Ministry of Health on January 2, 2019.
Form of products manufactured by the factory:
Hard capsules, Tablets, Film-coated tablets, Packaged products